Supportive Pentoxifylline in Falciparum Malaria: No Effect on Tumor Necrosis Factor Alpha Levels or Clinical Outcome: A Prospective, Randomized, Placebo-Controlled Study

Christoph Josef Hemmer Department of Medicine, Bernhard-Nocht-Institute for Tropical Medicine, Infectious Diseases and Clinical Immunology Section, University of Ulm, Department of Medicine, Hemostaseology Section, Philipps University, First Department of Medicine, University of Heidelberg, Department of Biometry and Medical Documentation, University of Ulm, Hamburg, Germany

Search for other papers by Christoph Josef Hemmer in
Current site
Google Scholar
PubMed
Close
,
Gabi Hort Department of Medicine, Bernhard-Nocht-Institute for Tropical Medicine, Infectious Diseases and Clinical Immunology Section, University of Ulm, Department of Medicine, Hemostaseology Section, Philipps University, First Department of Medicine, University of Heidelberg, Department of Biometry and Medical Documentation, University of Ulm, Hamburg, Germany

Search for other papers by Gabi Hort in
Current site
Google Scholar
PubMed
Close
,
Collins Batsirai Chiwakata Department of Medicine, Bernhard-Nocht-Institute for Tropical Medicine, Infectious Diseases and Clinical Immunology Section, University of Ulm, Department of Medicine, Hemostaseology Section, Philipps University, First Department of Medicine, University of Heidelberg, Department of Biometry and Medical Documentation, University of Ulm, Hamburg, Germany

Search for other papers by Collins Batsirai Chiwakata in
Current site
Google Scholar
PubMed
Close
,
Rainer Seitz Department of Medicine, Bernhard-Nocht-Institute for Tropical Medicine, Infectious Diseases and Clinical Immunology Section, University of Ulm, Department of Medicine, Hemostaseology Section, Philipps University, First Department of Medicine, University of Heidelberg, Department of Biometry and Medical Documentation, University of Ulm, Hamburg, Germany

Search for other papers by Rainer Seitz in
Current site
Google Scholar
PubMed
Close
,
Rudolf Egbring Department of Medicine, Bernhard-Nocht-Institute for Tropical Medicine, Infectious Diseases and Clinical Immunology Section, University of Ulm, Department of Medicine, Hemostaseology Section, Philipps University, First Department of Medicine, University of Heidelberg, Department of Biometry and Medical Documentation, University of Ulm, Hamburg, Germany

Search for other papers by Rudolf Egbring in
Current site
Google Scholar
PubMed
Close
,
Wilhelm Gaus Department of Medicine, Bernhard-Nocht-Institute for Tropical Medicine, Infectious Diseases and Clinical Immunology Section, University of Ulm, Department of Medicine, Hemostaseology Section, Philipps University, First Department of Medicine, University of Heidelberg, Department of Biometry and Medical Documentation, University of Ulm, Hamburg, Germany

Search for other papers by Wilhelm Gaus in
Current site
Google Scholar
PubMed
Close
,
Josef Hogel Department of Medicine, Bernhard-Nocht-Institute for Tropical Medicine, Infectious Diseases and Clinical Immunology Section, University of Ulm, Department of Medicine, Hemostaseology Section, Philipps University, First Department of Medicine, University of Heidelberg, Department of Biometry and Medical Documentation, University of Ulm, Hamburg, Germany

Search for other papers by Josef Hogel in
Current site
Google Scholar
PubMed
Close
,
Marcus Hassemer Department of Medicine, Bernhard-Nocht-Institute for Tropical Medicine, Infectious Diseases and Clinical Immunology Section, University of Ulm, Department of Medicine, Hemostaseology Section, Philipps University, First Department of Medicine, University of Heidelberg, Department of Biometry and Medical Documentation, University of Ulm, Hamburg, Germany

Search for other papers by Marcus Hassemer in
Current site
Google Scholar
PubMed
Close
,
Peter Paul Nawroth Department of Medicine, Bernhard-Nocht-Institute for Tropical Medicine, Infectious Diseases and Clinical Immunology Section, University of Ulm, Department of Medicine, Hemostaseology Section, Philipps University, First Department of Medicine, University of Heidelberg, Department of Biometry and Medical Documentation, University of Ulm, Hamburg, Germany

Search for other papers by Peter Paul Nawroth in
Current site
Google Scholar
PubMed
Close
,
Peter Kern Department of Medicine, Bernhard-Nocht-Institute for Tropical Medicine, Infectious Diseases and Clinical Immunology Section, University of Ulm, Department of Medicine, Hemostaseology Section, Philipps University, First Department of Medicine, University of Heidelberg, Department of Biometry and Medical Documentation, University of Ulm, Hamburg, Germany

Search for other papers by Peter Kern in
Current site
Google Scholar
PubMed
Close
, and
Manfred Dietrich Department of Medicine, Bernhard-Nocht-Institute for Tropical Medicine, Infectious Diseases and Clinical Immunology Section, University of Ulm, Department of Medicine, Hemostaseology Section, Philipps University, First Department of Medicine, University of Heidelberg, Department of Biometry and Medical Documentation, University of Ulm, Hamburg, Germany

Search for other papers by Manfred Dietrich in
Current site
Google Scholar
PubMed
Close
Restricted access

Pentoxifylline (POF) may suppress overproduction of tumor necrosis factor alpha (TNFα), which is thought to contribute to complications of human falciparum malaria. However, POF is believed to improve impaired capillary blood flow, which can be impaired in falciparum malaria. To test whether POF affects TNFα serum levels or other variables in this disease, we administered POF (20 mg/kg/day intravenously in 150 ml of saline for five days) randomized versus placebo (150 ml of saline without POF) in addition to standard antimalarial therapy. After recruitment of 51 patients with Plasmodium falciparum malaria, those receiving POF had more nausea and abdominal discomfort than the placebo group, as expected. Eleven of 27 patients receiving POF and three of 24 patients receiving placebo requested termination of the study medication (P < 0.05). Pentoxifylline did not change the decrease of TNFα levels or affect the clinical course in a significant way. Since POF failed to improve the clinical situation or to impact numerous laboratory parameters (including TNFα, thrombin-antithrombin III, thrombomodulin, and human neutrophil elastase), the study was terminated earlier than planned. While this study does not specifically address cerebral complications of malaria, the results suggest that POF is not useful as a routine adjunct to the standard therapy of falciparum malaria.

Author Notes

Save